Skip to main content
hpa logo
Topics A-Z:
Search the site:
Home › Topics › Infectious Diseases › Reference Library ›Injecting Drug Use (IDU) references
Printer friendly page (opens in new window)

Injecting Drug Use (IDU) references

Recent publications of interest

  • Modelling the hepatitis B vaccination programme in prisons AJ Sutton, NJ Gay, WJ Edmunds, NJ Andrews, VD Hope, RL Gilbert, M Piper, ON Gill . Epidemiology & Infection, 2006;134:231-242.
  • Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales and Northern Ireland: where are we now? AE Brown, SE Tomkins, LE Logan, DS LaMontagne, H Munro, VD Hope, A Righarts, JE Blackham, BD Rice, TR Chadborn, PA Tookey, JV. Parry, ON Gill, KA Fenton. Sexual Transmitted Infections, 2006;82:4-10.
  • Akbulut D, Dennis J, Gent M, Grant KA, Hope V, Ohai C, McLauchlin J, Mithani V, Mpagmugo O, Ncube F, de Souza-Thomas L. Wound Botulism in injectors of drugs: upsurge in cases in England during 2004. Euro Surveillance 2005;10:172-174.
  • Outbreak report: Wound botulism in injectors of illicit drugs: upsurge in cases in England during 2004. D Akbulut, J Dennis, M Gent, KA Grant, V Hope, C Ohai, J McLauchlin, V Mithani, O Mpamugo, F Ncube. EuroSurveillance Monthly 2005;10(9):September.
  • HIV prevalence among Injecting Drug Users in England & Wales 1990 to 2003: Evidence for increased transmission in recent years. VD Hope, A Judd, M Hickman, A Sutton, GV Stimson, JV Parry & ON Gill. AIDS 2005;19:1207-1214.
  • Modelling the Characteristics of the Males Injecting Drug User Population in England and Wales. AJ Sutton, NJ Gay, WJ Edmunds, NJ Andrews, VD Hope, ON Gill. International Journal of Drug Policy 2005;16:176-182 .
  • Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales. N Craine, AM Walker, S Williamson, A Brown, VD Hope. Commun Dis Public Health 2004;7:216-9
  • Brett MM, Hallas G, Mpamugo O. Wound botulism in the UK and Ireland. Journal of Medical Microbiology 2004;53:555-61
  • Engler KH, Perrett K. Group A streptococcal bacteraemia in Yorkshire and the Humber: evidence of another problematic infection amongst injecting drug users. Communicable Disease and Public Health 2004: 7;123-127
  • Perrett K, Granerød J, Crowcroft N, Carlisle R. Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users? Communicable Disease and Public Health 2003; 6:97-100
  • Efstratiou A, Emery M, Lamagni TL, Tanna A, Warner M, George RC. Increasing incidence of group A streptococcal infections amongst injecting drug users in England and Wales. Journal of Medical Microbiology 2003; 52:525
  • Brazier JS, TE Morris, Duerden BI. Heat and acid tolerance of Clostridium novyi Type A spores and their survival prior to preparation of heroin for injection. Anearobe 2003; 9:141-144
  • VD Hope; PA Rogers; L Jordan; TC Paine; S Barnett; JV Parry; ON Gill. Sustained increase in the sharing of needles and syringes among drug users in England and Wales AIDS 2002; 16:2494-2496
  • Jones JA, Salmon J, Djuretic T, Nichols G, Gill ON, on behalf of the investigation team. An outbreak of serious illness and death among injecting drug users in England during 2000. J Med Microbiol 2002; 51:978-84
  • McLauchlin J, Mithani V, Bolton FJ, Nichols GL, Bellis MA, Syed Q et al. An investigation into the microflora of heroin. J ournal of Medical Microbiology 2002; 51:1001-8
  • VD Hope, A Judd, M Hickman, T Lamagni, G Hunter, GV Stimson, S. Jones, L Donovan, JV Parry, and ON Gill. Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? Am J Public Health 2001; 91:38-42
  • TL Lamagni, VD Hope, KL Davison, JV Parry, and ON Gill. Failure to vaccinate current injecting drug users against hepatitis B in England and Wales. Commun Dis Public Health 2001; 4:71-72
  • Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000 Jun; 3:121-6
  • PHLS CDSC/CPHL team investigating unexplained severe illness and deaths in injecting drug users. Drug related deaths - causes and numbers. Lancet 2000; 356: 1277-8
  • TL Lamagni, KL Davison, VD Hope, JW Luutu, JA Newham, JV Parry, and ON Gill. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Commun Dis Public Health 1999; 2:174-177
  • ME Ramsay, MA Balogun, M Collins, V Balraj. Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996. Commun Dis Public Health 1998; 1: 89-94
  • C Crampin, TL. Lamagni, VD Hope, JA Newham, KM Lewis, JV Parry, and ON Gill. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Epidemiol Infect 1998; 121:381-386
  • PB Madden, T Lamagni, V Hope, D Bennett, D Goldberg. The HIV epidemic in Injecting Drug Users. Commun Dis Rep CDR Rev 1997;22: 7:R128-30
  • AJDurante, J Heptonstall. How many people in England and Wales risk infection from Injecting Drug Users? Commun Dis Rep CDR Rev 1995; 5:R40-4
  • AJ Durante, G. Hart, AR Brady, PB Madden, A Noone. The Health of the Nation target on syringe sharing: a role for routine surveillance in assessing progress and targeting interventions. Addiction 1995; 90:1389-96
  • A Noone, AJ Durante, AR Brady, F Majid, AV Swan, and JV Parry. HIV infection in IDUs attending centres in England and Wales; 1990-1991. AIDS 1993; 7:1501-1507.